Artemether Attenuates the Progression of Non-small Cell Lung Cancer by Inducing Apoptosis, Cell Cycle Arrest and...

Area of Science:

• Oncology
• Pharmacology
• Molecular Biology

Background:

• Non-small cell lung cancer (NSCLC) is the leading cause of cancer mortality.
• Artemisinin derivatives, like artemether (ART), are explored for their anti-cancer properties.

Purpose of the Study:

• To investigate the anti-proliferative effects of artemether (ART) on non-small cell lung cancer (NSCLC) cells.
• To elucidate the molecular mechanisms underlying ART's action in NSCLC.

Main Methods:

• Cell proliferation assays were performed on NSCLC cells treated with varying concentrations of ART.
• Apoptosis, cell cycle progression, DNA damage, and senescence markers were analyzed.
• Gene and protein expression levels of key regulatory molecules were quantified.

Main Results:

• ART significantly inhibited NSCLC cell proliferation in a dose- and time-dependent manner.
• High ART concentrations induced apoptosis by down-regulating Bcl-2, cIAP1, and cIAP2.
• Low ART concentrations caused cell cycle arrest by inhibiting cell cycle-related genes and induced DNA double-strand breaks and senescence via p16 upregulation.

Conclusions:

• Artemether (ART) exhibits potent anti-NSCLC activity through multiple mechanisms.
• ART induces apoptosis, cell cycle arrest, and cellular senescence in NSCLC cells.
• ART represents a promising therapeutic candidate for NSCLC, acting independently of p53.